Patent ID: 11970469
Assignee: THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 8:
9. A compound, or a salt or solvate thereof, selected from the group consisting of:
N-(4-((dimethylamino)methyl)phenyl)-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-3,3′-dimethoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-2-fluoro-3,3′-dimethoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-4′-fluoro-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-3′,4′-difluoro-5′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-3′-fluoro-5′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-3′-methoxy-5′-methyl-[1,1′-biphenyl]-4-amine;
N-(3,5-dimethylphenyl)-2-fluoro-3,3′-dimethoxy-[1,1′-biphenyl]-4-amine;
N-(3,5-dimethylphenyl)-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(5-((dimethylamino)methyl)-2-methylphenyl)-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(3-((2,6-dimethylmorpholino)methyl)phenyl)-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((2,6-dimethylmorpholino)methyl)phenyl)-3′-methoxy-[1,1′-biphenyl]-4-amine;
N-(4-((dimethylamino)methyl)phenyl)-2-methoxy-6-(3-methoxyphenyl)pyridin-3-amine;
N-(3-((dimethylamino)methyl)phenyl)-2-methoxy-6-(3-methoxyphenyl)pyridin-3-amine;
N-(4-((dimethylamino)methyl)phenyl)-6-(3-methoxyphenyl)pyridin-3-amine;
3-((3′-methoxy-[1,1′-biphenyl]-4-yl)amino)-N-(piperidin-4-ylmethyl)benzamide;
N-(4-((dimethylamino)methyl)phenyl)-3′-methoxy-4′-methyl-[1,1′-biphenyl]-4-amine;
4-((3′-methoxy-[1,1′-biphenyl]-4-yl)amino)-N-(piperidin-4-ylmethyl)benzamide;
N-((1-benzylpiperidin-4-yl)methyl)-4-((3′-methoxy-[1,1′-biphenyl]-4-yl)amino)benzamide;
4-((3′-methoxy-[1,1′-biphenyl]-4-yl)amino)-N-((1-methy 1piperidin-4-yl)methyl)benzamide; and
4-((3′,4′-difluoro-5′-methoxy-[1,1′-biphenyl]-4-yl)amino)-N-((1-methylpiperidin-4-yl)methyl)benzamide.